The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: Roles in cytokine-dependent survival and proliferative responses

Cancer Research

Volumn 60, Issue 23, 2000, Pages 6763-6770

  Tu, Y ^a   Gardner, A ^a   Lichtenstein, A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; WORTMANNIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME MECHANISM; HUMAN; HUMAN CELL; HYBRIDOMA; MULTIPLE MYELOMA; PLASMACYTOMA; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MULTIPLE MYELOMA; PLASMACYTOMA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0034548453     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma
2. Response patterns of purified myeloma cells to hematopoietic growth factors
3. Interleukin-6 prevents dexamethasone-induced myeloma cell death
4. Interleukin-6 inhibits apoptosis of malignant plasma cells
5. Insulin-like growth factor is a growth and survival factor in human multiple myeloma cell lines
6. Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors
7. Differential effect of growth hormone and insulin-like growth factor I, insulin-like growth factor II and insulin on Ig production and growth in human plasma cells
8. Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by IL-6
9. Insulin-like growth factor I regulates pro-B cell differentiation
10. IL-6 inhibits fas-induced apoptosis and stress activated protein kinase activation in multiple myeloma cells
11. IL-6-induced inhibition of multiple myeloma cell apoptosis: Support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway
12. Recombinant IL-6 activates p42 and p44 MAP kinases in the IL-6-responsive B cell line AF-10
13. IL-6 triggers multiple myeloma cell growth via the Ras dependent mitogen activated protein kinase cascade
14. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
15. AKT, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line
16. IGF-I inhibits apoptosis using the phosphatidylinositol 3-kinase and MAP kinase pathways
17. Activation of phosphatidylinositol 3-kinase by IGF-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes
18. Interleukin-6 inhibits transforming growth factor-B-induced apoptosis through the phosphatidylinositol 3-kinase/AKT and signal transducers of transcription pathway
19. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI 3-kinase to the PDGF receptor
20. Phosphorylation of the PDGF receptor β subunit creates a tight binding site for phosphatidylinositol 3-kinase
21. Phosphoroinositide kinases
22. Dual role of phosphatidylinositol-3,4,5 triphosphate in the activation of protein kinase B
23. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase AKT through its pleckstrin homology domain
24. The protein kinase encoded by the AKT proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
25. Taxol can induce phosphorylation of BCL-2 in multiple myeloma cells and potentiate dexamethasone-induced apoptosis
26. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action
27. Adenovirus vector-based purging of multiple myeloma cells
28. Efficient adenovirus-mediated gene expression in malignant human plasma cells: Relative lymphoid cell resistance
29. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
30. Interleukin 3-dependent survival by the AKT protein kinase
31. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and raf-1/MAP kinase pathway activation
32. An activated mutant of R-ras inhibits cell death caused by cytokine deprivation in BaF3 cells in the presence of IGF-I
33. The 70 kDa S6 kinase: Regulation of a kinase with multiple roles in mitogenic signaling
34. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression
35. Interleukin-3-induced phosphorylation of BAD through the protein kinase AKT
36. Intermediate affinity IL-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway
37. Rho prevents apoptosis through BCL-2 expression: Implications for IL-2 receptor signal transduction
38. Transformation of hematyopoietic cells by BCR/ABL requires activation of a PI-3K/AKT-dependent pathway
39. Dexamethasone induces apoptosis of myeloma cells in a JNK/SAP kinase independent mechanism
40. Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization and IGF-I-mediated survival of cerebellar granule cells
41. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors
42. Biphasic activation of p21 ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase
43. Blockade of MAP kinase cascade signaling in IL-6-independent multiple myeloma cells
44. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes
45. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor
46. Vav is associated with signal transducing molecules gp 130, Grb2 and Erk2, and is phosphorylated in response to IL-6
47. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell prolliferation and phosphatidylinositol 3-kinase activity
48. Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase
49. Expression and location of pro-apoptotic BCL-2 family protein BAD in normal human tissues and tumor cell lines